Navigation Links
Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Date:4/26/2012

ales of active pharmaceutical ingredients. In addition, third party net revenues in Japan were favorably impacted by overall market growth. Offsetting these increases was a decline in sales in Australia, as a result, in the current quarter, of the most significant government-imposed pricing reform in the country's history.

For the quarter ended March 31, 2012, Mylan's Specialty segment reported third party net revenues of $162.3 million, an increase of $65.3 million, or 67.3%, from the comparable prior year period of $97.0 million. The most significant contributor to Specialty segment revenues continues to be the EPIPEN® auto-injector, sales of which increased as a result of favorable pricing and growth in both the overall market and Mylan's market share. The EPIPEN® auto-injector is the number one epinephrine auto-injector for the treatment of severe allergic reactions and maintains a market share in excess of 95% in the United States.

Gross profit for the quarter ended March 31, 2012 was $666.3 million and gross margins were 41.8%.  In the comparable prior year period, gross profit was $590.9 million, and gross margins were 40.8%. Adjusted gross profit for the quarter ended March 31, 2012 was $760.0 million and adjusted gross margins were 48% as compared to adjusted gross profit of $681.8 million and adjusted gross margins of 47% in the comparable prior year period. The increase in adjusted gross margins was primarily the result of new product introductions in North America and favorable pricing on the EPIPEN® auto-injector, partially offset by the impact of pricing reductions in all regions of our generics segment. 

Earnings from operations were $246.4 million for the quarter ended March 31, 2012, compared to $211.7 million for the comparable prior year period.  Adjusted earnings from operations for the quarter ended March 31, 2012 was $368.3 million as compared to adjusted earnings from operations of $33
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
2. Mylan Launches Generic Version of Zyprexa® Tablets
3. Mylan Launches First Generic Version of Lescol® Capsules
4. Mylan Schedules First Quarter 2012 Financial Results Conference Call and Live Webcast
5. Mylan One of First to Launch Generic Version of Boniva®
6. Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®
7. Mylan Continues to Pursue Damages and Injunction Against Sunovions Brovana® in Ongoing Litigation
8. Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA
9. Mylan Secures an Additional $300 Million of Committed Financing
10. Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
11. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Intec Pharma Ltd. (the "Company") (NASDAQ: ... developing drugs based on its proprietary Accordion Pill platform ... offering in the United States ... to the public of $6.00 per ordinary share, before ... are being offered by the Company.  In addition, the ...
(Date:8/4/2015)... , August 4, 2015 ... with market overview, trends, DRO analysis, market segmentation, ... competitive scenario and top competitor profiles in: ... Testing Market Development and Demand Forecast to 2020  ... Explore full reports with detailed TOC ...
(Date:8/4/2015)... -- Second Quarter 2015 Highlights: , ... of 2014 , Net earnings attributable to Team Health ... adjustments , Diluted net earnings per share of $0.39; ... to $99.4 million 2015 Outlook: , ... 24.0% to 26.0%; Adjusted EBITDA margin remains between 10.5% and ...
Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 3Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 4Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 6Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 7Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 8Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 9Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 10Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 11Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 12Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 13Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 14Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 15Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 16Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 17Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 18Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 19Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 20Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 21Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 22Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 23Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 24Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 25Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 26Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 27Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 28Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 29Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 30
... 2011 The grand opening ceremony for the world,s largest ... RNL BIO ( www.rnl.co.kr ), South Korea,s premier ... stem cell medical center in Beijing, China. Beijing RNL Stem ... Research Institute" (President : Li Hailing, www.yandaco.com ). Beijing ...
... harder to crush version of OxyContin® has a lower ... at a conference of law enforcement officers today. Last ... announced that every day 100 people die from drug ... pain relievers. A new formulation of the opioid pain ...
Cached Medicine Technology:RNL Opens the World's Largest Stem Cell Medical Center in Beijing, China 2New OxyContin® Has Lower Street Price Than Old Crushable Formulation 2
(Date:8/4/2015)... ... 04, 2015 , ... Driving skills may decline with age, ... the August 2015 Harvard Health Letter. , "Age and health conditions aren't enough ... assessment of skills," says Lissa Kapust, a social worker at Harvard-affiliated Beth Israel ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... party supplies, arts and crafts, toys, novelties, and school supplies, has developed engaging ... , The exclusive collection includes student rewards, classroom decorations, crafts and ...
(Date:8/4/2015)... ... ... than 700 years of marital bliss were celebrated as 13 couples from Friendship Village ... and Richard Oas lead the non-denominational service for married couples wishing to reaffirm their ... the Moonlight Serenade Orchestra and a special honeymoon dinner featuring lobster and steak. , ...
(Date:8/4/2015)... Orleans, LA (PRWEB) , ... August 04, 2015 ... ... Catholic institution of higher learning, announced today that its RN to BSN and ... programs have been awarded full accreditation through June 2020 from the Commission ...
(Date:8/4/2015)... ... August 04, 2015 , ... Lightning Labels is pleased to ... that will usher in a new standard of sticker and label-making for the ... meet its twin objectives of quality and quantity without compromising the signature lightning-fast ...
Breaking Medicine News(10 mins):Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 2Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 3Health News:Couples Renew Vows at Friendship Village of Schaumburg 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 4Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3
... internal molecular clock in controlling blood// pressure. , ... strokes occur most frequently in the early-morning hours. Published online ... Sciences, this report points to the novel possibility of modifying ... ,The upswing in heart attacks tracks with rising blood ...
... will be diagnosed with cancer of the colon and rectum ... yearly basis, today’s genetic research news offers some optimism. ... Proceedings of the National Academy of Sciences, led by Zhenghe ... Western Reserve University School of Medicine and Case Comprehensive Cancer ...
... stem cell-based regenerative medicine will help repair diseased tissue. ... epigenetic signals that give stem cells their unique ability ... ,The hype over epigenetic research is because ... manipulating epigenetic marks, cells can be transformed into other ...
... were dug out from the gutter of Ratlam's Christian Hospital ... following recovery of the bones, was granted bail. ... bones of infants, suspected to be of aborted fetuses and ... to 437 from 391 bone pieces found Saturday night. ...
... pointed out that women with a 34 inch waist carry twice ... women who boast of trimmer waists. ,Nearly 5500 women ... by 19% as compared to the figures in 1990. Women fifty ... grave risks encountered by the present lot. ...
... bring down the androgen levels in women. This was reported ... ,Hirsutism is a condition which is characterized by growth ... women. This is mainly due to an increased level of ... ,Spearmint was used in earlier studies to bring down ...
Cached Medicine News:Health News:Reset Your Biological Clock and Prevent Heart Attack! 2Health News:Researchers Identify Cell Pathway in Colon Cancer 2Health News:Epigenetics to Shape Stem Cell Future 2Health News:More Bones of Aborted Fetuses Recovered from Hospital Premises 2Health News:Cancer Risk Pronounced in Women With an Ample Waist 2
... Sprinter balloon incorporates advanced technology, ... crossing ability in the toughest ... will is offered in a ... from the 2.0 4.0 ...
Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea...
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
Medicine Products: